According to the 2021 Restricted Stock Unit Plan, Simcere Pharma (02096) has granted a total of 2.169 million restricted stock units.

date
20:18 26/03/2026
avatar
GMT Eight
Sinopharm Holdings (02096) announced that on March 26, 2026, it approved the grant of a total of 2.169 million restricted stock units (equivalent to 2.169 million shares of the relevant shares) at zero cost under the 2021 Restricted Stock Unit Plan to a total of 54 eligible participants, pending acceptance by the grantees.
SIMCERE PHARMA (02096) announced that on March 26, 2026, it has resolved to grant a total of 2.169 million restricted share units (equivalent to 2.169 million shares of the relevant stock) to a total of 54 eligible participants under the 2021 Restricted Share Units Plan at zero cost, subject to acceptance by the grantee.